Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Earnings call highlights include strong future operating income projections, a positive market demand outlook, and substantial price increases in aerospace LTAs. Despite some challenges in medical distribution, the overall sentiment is optimistic, with significant growth in aerospace and energy markets. The Q&A section supports this with expectations of sequential growth in key metrics and improved adoption in the additive business. While some management responses were vague, the overall guidance and positive trends suggest a positive stock price movement.
Operating Income $155 million in the second quarter, a 31% increase over the second quarter of fiscal year 2025. The increase is attributed to solid execution, strong market position, and unique capacity and capabilities.
SAO Segment Adjusted Operating Margin 33.1% in the quarter, compared to 28.3% a year ago and 32% in the prior quarter. The increase is driven by increased productivity, product mix optimization, and pricing actions.
SAO Segment Operating Income $174.6 million, an increase of 29% year-over-year, attributed to expanding margins and strong execution.
Aerospace and Defense End-Use Market Sales Up 15% year-over-year but down 1% sequentially. The year-over-year increase is due to strengthening demand, while the sequential decline is attributed to seasonal factors.
Medical End-Use Market Sales Down 22% year-over-year and 7% sequentially. The decline is isolated to certain titanium products for specific medical distribution customers.
Energy End-Use Market Sales Up 19% year-over-year but down 10% sequentially. The year-over-year increase is driven by power generation demand, while the sequential decline is due to order frequency and production scheduling.
Gross Profit $218.3 million, up 23% from the same quarter last year. The increase is due to improving productivity, product mix, and pricing.
SG&A Expenses $63.1 million, up $4.5 million from the same quarter last year. The increase is attributed to higher corporate costs.
Adjusted Earnings Per Diluted Share $2.33 for the quarter, excluding the impact of debt refinancing.
PEP Segment Net Sales $77.2 million, down 10% year-over-year and 11% sequentially. The decline is primarily driven by lower demand for titanium sales from specific medical customers.
PEP Segment Operating Income $6.9 million, compared to $7 million in the same quarter a year ago. The year-over-year improvement in operating margin reflects increasing sales in the additive business and cost benefits from structural cost reductions.
Cash from Operating Activities $132.2 million in the current quarter.
Capital Expenditures $46.3 million in the current quarter.
Adjusted Free Cash Flow $85.9 million in the current quarter.
Nickel-based superalloys: Carpenter Technology is investing in a brownfield capacity expansion project to add 9,000 additional tons of nickel-based superalloys, representing a 7% increase over 2019 shipment levels. This is the only announced capacity expansion in the market since 2019.
Aerospace and defense: Strong demand growth, with commercial aerospace bookings up 23% sequentially and aerospace engine material orders up 30% sequentially. Defense submarket orders were down due to government shutdowns.
Medical: Sales down 7% sequentially and 22% year-over-year due to lower demand for titanium products from specific customers. However, orthopedic and dental submarkets remain strong.
Energy: Sales up 19% year-over-year, driven by power generation demand for data centers and developing economies.
Operating income: Achieved record operating income of $155 million, a 31% increase year-over-year. SAO segment margins reached 33.1%, marking the 16th consecutive quarter of margin expansion.
Free cash flow: Generated $85.9 million in adjusted free cash flow in the quarter, with a full-year target of at least $280 million.
Pricing strategy: Completed three long-term agreements with aerospace customers, achieving significant price increases. Pricing actions are expected to remain a positive tailwind due to supply-demand imbalances.
Capital allocation: Continued share repurchase program with $183.1 million spent to date and ongoing investments in growth projects like the brownfield expansion.
Defense Submarket Orders: Orders were down materially in the quarter due to the government shutdown and uncertainty in terms of the defense budget.
Medical End-Use Market: Sales were down 7% sequentially and 22% compared to the prior year second quarter, primarily due to decreased demand for certain titanium products from specific medical distribution customers.
Energy End-Use Market: Sales were down 10% sequentially, reflecting fluctuations in power generation demand and the frequency of orders.
Nickel-Based Super Alloy Supply: There is a significant supply-demand imbalance for nickel-based super alloys, with no meaningful increases in overall qualified supply since 2019, except for Carpenter Technology's modest capacity expansion.
Titanium Sales Impact: Lower demand from specific medical customers heavily impacted titanium sales, affecting the PEP segment's performance.
Regulatory and Budgetary Uncertainty: Uncertainty in defense budgets and government shutdowns have negatively impacted defense submarket orders.
SAO Segment Margins: The SAO segment is expected to continue expanding margins over the next two quarters of fiscal year 2026, driven by increased productivity, product mix optimization, and pricing actions.
Aerospace and Defense Market Demand: Strengthening demand is anticipated, with commercial aerospace bookings up 23% sequentially and aerospace engine material orders up 30% sequentially. Structural submarket customers are ramping up order placements, signaling confidence in the aerospace ramp.
Pricing Trends: Pricing is expected to remain a positive tailwind due to strong demand and supply constraints, particularly in nickel-based superalloys. Long-term agreements with significant price increases have been completed.
Operating Income Guidance: For the third quarter of fiscal year 2026, total operating income is projected to be $177 million to $182 million, with SAO contributing $195 million to $200 million and PEP around $7 million.
Fiscal Year 2026 Guidance: Operating income guidance for fiscal year 2026 has been raised to $680 million to $700 million, representing a 30% to 33% increase over fiscal year 2025.
Nickel-Based Superalloy Supply and Demand: Demand for nickel-based superalloys is expected to accelerate due to increasing aerospace OEM builds, MRO demand, defense, space, and power generation needs. Supply constraints are anticipated to persist, driving pricing dynamics.
Capital Expenditures and Free Cash Flow: Capital spending is expected to accelerate in the second half of fiscal year 2026, with at least $280 million in adjusted free cash flow projected for the year. The brownfield expansion project is on budget and schedule.
Long-Term Earnings Growth: The company aims to exceed fiscal year 2027 guidance of $765 million to $800 million in operating income, with plans for further growth beyond 2027.
Quarterly Dividend: The company continues to fund a recurring and long-standing quarterly dividend as part of its capital allocation strategy.
Share Repurchase Program: The company repurchased $32.1 million of shares in the current quarter, bringing the total to $183.1 million spent to date against the $400 million authorization announced in July 2024.
Earnings call highlights include strong future operating income projections, a positive market demand outlook, and substantial price increases in aerospace LTAs. Despite some challenges in medical distribution, the overall sentiment is optimistic, with significant growth in aerospace and energy markets. The Q&A section supports this with expectations of sequential growth in key metrics and improved adoption in the additive business. While some management responses were vague, the overall guidance and positive trends suggest a positive stock price movement.
The earnings call reveals strong financial performance with record profitability and increased operating margins. Despite a decline in medical market sales, other segments like aerospace and defense show robust growth. The Q&A section highlights extended jet engine alloy lead times, indicative of strong demand. The company's positive outlook for FY '26 and '27, along with strategic projects like the brownfield expansion, further support optimism. Shareholder returns through dividends and a stock buyback program add to the positive sentiment. Overall, the stock is likely to experience a positive movement of 2% to 8%.
The earnings call indicates strong financial performance with a 48% increase in adjusted operating income and significant free cash flow. The company is also committed to shareholder returns through stock repurchases. The Q&A reveals positive sentiment with strong demand in aerospace and defense, and no significant pricing pressure in key markets. Despite some inventory concerns, the overall outlook is optimistic, supported by strategic maintenance and market expansion plans. These factors suggest a positive stock price movement over the next two weeks.
The earnings call summary indicates strong financial performance with significant increases in operating income, gross profit, and cash flow. The Q&A section reveals positive order trends and management's confidence in future demand and pricing improvements. The company's share repurchase program and liquidity position further support a positive outlook. Despite some uncertainties in pricing specifics, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.